Research ArticleClinical Investigation
Validation of an Artificial Intelligence–Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma
Maria C. Ferrández, Sandeep S.V. Golla, Jakoba J. Eertink, Sanne E. Wiegers, Gerben J.C. Zwezerijnen, Martijn W. Heymans, Pieternella J. Lugtenburg, Lars Kurch, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Sally F. Barrington, N. George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sándor Czibor, Tamás Györke, Martine E.D. Chamuleau, Josée M. Zijlstra and Ronald Boellaard; on behalf of the PETRA Consortium
Journal of Nuclear Medicine November 2024, 65 (11) 1802-1807; DOI: https://doi.org/10.2967/jnumed.124.268191
Maria C. Ferrández
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands;
Sandeep S.V. Golla
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands;
Jakoba J. Eertink
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands;
3Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;
Sanne E. Wiegers
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands;
Gerben J.C. Zwezerijnen
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands;
Martijn W. Heymans
4Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;
Pieternella J. Lugtenburg
5Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands;
Lars Kurch
6Clinic and Polyclinic for Nuclear Medicine, Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany;
Andreas Hüttmann
7Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
Christine Hanoun
7Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
Ulrich Dührsen
7Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
Sally F. Barrington
8School of Biomedical Engineering and Imaging Sciences, King’s College London and Guy’s and St Thomas’ PET Centre, King’s Health Partners, King’s College London, London, United Kingdom;
N. George Mikhaeel
9Department of Clinical Oncology, Guy’s Cancer Centre and School of Cancer and Pharmaceutical Sciences, King’s College London, London, United Kingdom;
Luca Ceriani
10Department of Nuclear Medicine and PET/CT Centre, Imaging Institute of Southern Switzerland–EOC, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland;
11SAKK Swiss Group for Clinical Cancer Research, Bern, Switzerland;
Emanuele Zucca
11SAKK Swiss Group for Clinical Cancer Research, Bern, Switzerland;
12Department of Oncology, Oncology Institute of Southern Switzerland–EOC, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona, Switzerland;
13Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland; and
Sándor Czibor
14Department of Nuclear Medicine, Medical Imaging Centre, Semmelweis University, Budapest, Hungary
Tamás Györke
14Department of Nuclear Medicine, Medical Imaging Centre, Semmelweis University, Budapest, Hungary
Martine E.D. Chamuleau
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands;
3Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;
Josée M. Zijlstra
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands;
3Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;
Ronald Boellaard
1Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands;

SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 11
November 1, 2024
Validation of an Artificial Intelligence–Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma
Maria C. Ferrández, Sandeep S.V. Golla, Jakoba J. Eertink, Sanne E. Wiegers, Gerben J.C. Zwezerijnen, Martijn W. Heymans, Pieternella J. Lugtenburg, Lars Kurch, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Sally F. Barrington, N. George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sándor Czibor, Tamás Györke, Martine E.D. Chamuleau, Josée M. Zijlstra, Ronald Boellaard
Journal of Nuclear Medicine Nov 2024, 65 (11) 1802-1807; DOI: 10.2967/jnumed.124.268191
Validation of an Artificial Intelligence–Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma
Maria C. Ferrández, Sandeep S.V. Golla, Jakoba J. Eertink, Sanne E. Wiegers, Gerben J.C. Zwezerijnen, Martijn W. Heymans, Pieternella J. Lugtenburg, Lars Kurch, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Sally F. Barrington, N. George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sándor Czibor, Tamás Györke, Martine E.D. Chamuleau, Josée M. Zijlstra, Ronald Boellaard
Journal of Nuclear Medicine Nov 2024, 65 (11) 1802-1807; DOI: 10.2967/jnumed.124.268191
Jump to section
Related Articles
Cited By...
- No citing articles found.